Functional Screening of FxxLF-Like Peptide Motifs Identifies SMARCD1/BAF60a as an Androgen Receptor Cofactor that Modulates TMPRSS2 Expression

Tekijä van de Wijngaart, Dennis J., Dubbink, Hendrikus J., Molier, Michel, de Vos, Carola, Trapman, Jan, Jenster, Guido
Julkaisussa Mol Endocrinol (2009)

Systematic Structure-Function Analysis of Androgen Receptor Leu(701) Mutants Explains the Properties of the Prostate Cancer Mutant L701H

Tekijä van de Wijngaart, Dennis J., Molier, Michel, Lusher, Scott J., Hersmus, Remko, Jenster, Guido, Trapman, Jan, Dubbink, Hendrikus J.
Julkaistu 2010

Novel EGFR V834L Germline Mutation Associated With Familial Lung Adenocarcinoma

Tekijä van der Leest, Cor, Wagner, Anja, Pedrosa, Rute M., Aerts, Joachim G., Dinjens, Winand N.M., Dubbink, Hendrikus J.
Julkaisussa JCO Precis Oncol (2018)

Mitochondrial D310 mutation as clonal marker for solid tumors

Tekijä Geurts-Giele, Willemina R. R., Gathier, Gerard H. G. K., Atmodimedjo, Peggy N., Dubbink, Hendrikus J., Dinjens, Winand N. M.
Julkaisussa Virchows Arch (2015)

MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation

Tekijä Groenendijk, Floris H., Taal, Walter, Dubbink, Hendrikus J., Haarloo, Cathleen R., Kouwenhoven, Mathilde C., van den Bent, Martin J., Kros, Johan M., Dinjens, Winand N. M.
Julkaistu 2010

Impact of panel design and cut-off on tumour mutational burden assessment in metastatic solid tumour samples

Tekijä Mankor, Joanne M., Paats, Marthe S., Groenendijk, Floris H., Roepman, Paul, Dinjens, Winand N. M., Dubbink, Hendrikus J., Sleijfer, Stefan, Cuppen, Edwin, Lolkema, Martijn P. J. K.
Julkaisussa Br J Cancer (2020)

Compartmentalization of androgen receptor protein–protein interactions in living cells

Tekijä van Royen, Martin E., Cunha, Sónia M., Brink, Maartje C., Mattern, Karin A., Nigg, Alex L., Dubbink, Hendrikus J., Verschure, Pernette J., Trapman, Jan, Houtsmuller, Adriaan B.
Julkaistu 2007

Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics

Tekijä Synhaeve, Nathalie E., van den Bent, Martin J., French, Pim J., Dinjens, Winand N. M., Atmodimedjo, Peggy N., Kros, Johan M., Verdijk, R., Dirven, Clemens M. F., Dubbink, Hendrikus J.
Julkaisussa Acta Neuropathol Commun (2018)

Gynecological Surveillance and Surgery Outcomes in Dutch Lynch Syndrome Carriers

Tekijä Eikenboom, Ellis L., van Doorn, Helena C., Dinjens, Winand N. M., Dubbink, Hendrikus J., Geurts-Giele, Willemina R. R., Spaander, Manon C. W., Tops, Carli M. J., Wagner, Anja, Goverde, Anne
Julkaisussa Cancers (Basel) (2021)

Next generation diagnostic molecular pathology: Critical appraisal of quality assurance in Europe

Tekijä Dubbink, Hendrikus J., Deans, Zandra C., Tops, Bastiaan B.J., van Kemenade, Folkert J., Koljenović, S., van Krieken, Han J.M., Blokx, Willeke A.M., Dinjens, Winand N.M., Groenen, Patricia J.T.A.
Julkaisussa Mol Oncol (2014)

The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study

Tekijä Broen, Martinus P G, Smits, Marion, Wijnenga, Maarten M J, Dubbink, Hendrikus J, Anten, Monique H M E, Schijns, Olaf E M G, Beckervordersandforth, Jan, Postma, Alida A, van den Bent, Martin J
Julkaisussa Neuro Oncol (2018)

Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation

Tekijä Incekara, Fatih, van der Voort, Sebastian R., Dubbink, Hendrikus J., Atmodimedjo, Peggy N., Nandoe Tewarie, Rishi, Lycklama, Geert, Vincent, Arnaud J. P. E., Kros, Johan M., Klein, Stefan, van den Bent, Martin, Smits, Marion
Julkaisussa Front Oncol (2020)

Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial

Tekijä Dubbink, Hendrikus J., Atmodimedjo, Peggy N., Kros, Johan M., French, Pim J., Sanson, Marc, Idbaih, Ahmed, Wesseling, Pieter, Enting, Roelien, Spliet, Wim, Tijssen, Cees, Dinjens, Winand N. M., Gorlia, Thierry, van den Bent, Martin J.
Julkaisussa Neuro Oncol (2016)

Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma

Tekijä Wijnenga, Maarten M. J., French, Pim J., Dubbink, Hendrikus J., Dinjens, Winand N. M., Atmodimedjo, Peggy N., Kros, Johan M., Fleischeuer, Ruth, Dirven, Clemens M. F., Vincent, Arnaud J. P. E., van den Bent, Martin J.
Julkaisussa J Neurooncol (2018)

Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis

Tekijä van Poppelen, Natasha M., van Ipenburg, Jolique A., van den Bosch, Quincy, Vaarwater, Jolanda, Brands, Tom, Eussen, Bert, Magielsen, Frank, Dubbink, Hendrikus J., Paridaens, Dion, Brosens, Erwin, Naus, Nicole, de Klein, Annelies, Kiliç, Emine, Verdijk, Robert M.
Julkaisussa Int J Mol Sci (2021)

The Erasmus Glioma Database (EGD): Structural MRI scans, WHO 2016 subtypes, and segmentations of 774 patients with glioma

Tekijä van der Voort, Sebastian R., Incekara, Fatih, Wijnenga, Maarten M.J., Kapsas, Georgios, Gahrmann, Renske, Schouten, Joost W., Dubbink, Hendrikus J., Vincent, Arnaud J.P.E., van den Bent, Martin J., French, Pim J., Klein, Stefan, Smits, Marion
Julkaisussa Data Brief (2021)

Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA

Tekijä Bos, Manouk K., Nasserinejad, Kazem, Jansen, Maurice P. H. M., Angus, Lindsay, Atmodimedjo, Peggy N., de Jonge, Evert, Dinjens, Winand N. M., van Schaik, Ron H. N., Del Re, Marzia, Dubbink, Hendrikus J., Sleijfer, Stefan, Martens, John W. M.
Julkaisussa Mol Oncol (2020)

MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Stu...

Tekijä van den Bent, Martin J., Dubbink, Hendrikus J., Sanson, Marc, van der Lee-Haarloo, Cathleen R., Hegi, Monika, Jeuken, Judith W.M., Ibdaih, Ahmed, Brandes, Alba A., Taphoorn, Martin J.B., Frenay, Marc, Lacombe, Denis, Gorlia, Thierry, Dinjens, Winand N.M., Kros, Johan M.
Julkaistu 2009

Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria

Tekijä Tesileanu, C Mircea S, Dirven, Linda, Wijnenga, Maarten M J, Koekkoek, Johan A F, Vincent, Arnaud J P E, Dubbink, Hendrikus J, Atmodimedjo, Peggy N, Kros, Johan M, van Duinen, Sjoerd G, Smits, Marion, Taphoorn, Martin J B, French, Pim J, van den Bent, Martin J
Julkaisussa Neuro Oncol (2020)

The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis

Tekijä Wijnenga, Maarten M J, French, Pim J, Dubbink, Hendrikus J, Dinjens, Winand N M, Atmodimedjo, Peggy N, Kros, Johan M, Smits, Marion, Gahrmann, Renske, Rutten, Geert-Jan, Verheul, Jeroen B, Fleischeuer, Ruth, Dirven, Clemens M F, Vincent, Arnaud J P E, van den Bent, Martin J
Julkaisussa Neuro Oncol (2018)